Hanmi Pharmaceutical's board replaces CEO Park Jae-hyun and four directors, appointing HB Investment's Hwang Sang-yeon as new chief candidate amid ongoing management dispute between major shareholders and professional managers over company direction and founding principles.
#YonhapInfomax #HanmiPharmaceutical #CeoReplacement #HwangSangyeon #ManagementDispute #BoardRestructuring #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=109619
Hanmi Pharmaceutical Replaces CEO Park Jae-hyun, Names Hwang Sang-yeon as New Chief Candidate
Hanmi Pharmaceutical's board replaces CEO Park Jae-hyun and four directors, appointing HB Investment's Hwang Sang-yeon as new chief candidate amid ongoing management dispute between major shareholders and professional managers over company direction and founding principles.
Chairman Shin Dong-guk of Hanyang Precision acquired an additional 6.45% stake in Hanmi Science, raising his and the company’s combined holding to nearly 30%, amid heightened management tensions with Hanmi Pharmaceutical’s CEO.
#YonhapInfomax #HanmiScience #ShinDongGuk #StakeAcquisition #HanyangPrecision #ManagementDispute #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=106455
Chairman Shin Dong-guk Acquires Additional 6.45% Stake in Hanmi Science—Holding Approaches 30%
Chairman Shin Dong-guk of Hanyang Precision acquired an additional 6.45% stake in Hanmi Science, raising his and the company’s combined holding to nearly 30%, amid heightened management tensions with Hanmi Pharmaceutical’s CEO.
Park Cheol-wan, largest shareholder of Kumho Petrochemical, warns of legal action if the company issues exchangeable bonds secured by treasury shares, citing potential impact on management control amid ongoing governance disputes.
#YonhapInfomax #KumhoPetrochemical #ExchangeableBonds #TreasuryShares #ManagementDispute #ShareholderAction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=84177
Park Cheol-wan, Largest Shareholder of Kumho Petrochemical, Warns of Strong Action Against Issuance of Exchangeable Bonds Secured by Treasury Shares
Park Cheol-wan, largest shareholder of Kumho Petrochemical, warns of legal action if the company issues exchangeable bonds secured by treasury shares, citing potential impact on management control amid ongoing governance disputes.
Young Poong Corp. has filed a police complaint against Korea Zinc's top executives and ACT's CEO, alleging improper use of company funds to form a minority shareholder coalition and influence management control, intensifying the ongoing dispute over Korea Zinc's governance.
#YonhapInfomax #YoungPoong #KoreaZinc #ShareholderCoalition #ManagementDispute #FiduciaryDutyViolation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=81245
Young Poong Files Police Complaint Against Korea Zinc Chairman Choi Yoon-beom and ACT CEO Lee Sang-mok Over Alleged Shareholder Coalition Backroom Dealings
Young Poong Corp. has filed a police complaint against Korea Zinc's top executives and ACT's CEO, alleging improper use of company funds to form a minority shareholder coalition and influence management control, intensifying the ongoing dispute over Korea Zinc's governance.
Korea Zinc Co. has opted to skip its interim dividend for 2024, citing a 1.8 trillion won ($1.39 billion) share buyback and cancellation, while maintaining plans for a year-end payout at previous levels.
#YonhapInfomax #KoreaZinc #ShareBuyback #Dividend #TreasuryShares #ManagementDispute #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=76024
Korea Zinc Skips Interim Dividend, Citing 1.8 Trillion Won Share Buyback and Cancellation
Korea Zinc Co. has opted to skip its interim dividend for 2024, citing a 1.8 trillion won ($1.39 billion) share buyback and cancellation, while maintaining plans for a year-end payout at previous levels.
Kim Ki-soo, former No. 2 shareholder of Daol Investment & Securities, faces his first trial next week on charges of violating South Korea’s Capital Markets Act by failing to report large shareholdings during a high-profile management dispute.
#YonhapInfomax #DaolInvestmentSecurities #CapitalMarketsAct #KimKiSoo #ShareholdingDisclosure #ManagementDispute #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=71980
Daol Securities Management Dispute—First Trial for Former No. 2 Shareholder Next Week on Capital Markets Act Violation Charges
The first trial for Kim Ki-soo, former No. 2 shareholder of Daol Investment & Securities, will be held next week on charges of violating South Korea’s Capital Markets Act by failing to disclose large shareholdings, following a two-year management dispute that ended with the sale of his stake to DB Insurance.
KOSPI Remains Flat Despite US-China Trade Agreement; Hanjin KAL Hits Upper Limit on Potential Management Dispute
KOSPI closes flat at 2,608.42 despite US-China tariff reduction agreement, with Hanjin KAL hitting upper limit amid potential management dispute
Prosecutors Raid MBK Partners Following Korea Zinc Search
Prosecutors raid MBK Partners offices and executive residences, investigating potential legal violations in Korea Zinc management dispute, following earlier search of Korea Zinc
Daol Investment & Securities Stock Plunges 11% After Resolution of Management Dispute
Daol Investment & Securities stock drops 11% as management dispute resolves, with DB Insurance becoming new major shareholder through general investment
Yonhap Infomax News